UCAN CAN-DU, a unique collaborative network of Dutch and Canadian researchers.









project has received a 5.2 Million Euro (8 Million Canadian Dollars) to improve personalized medicine for children with arthritis. All academic pediatric rheumatology centers in The Netherlands, and 18 academic centers in Canada, participate in this project which was built on the foundation of UCAN-U. This 5-year project is funded by the Canadian Institutes of Health Research (CIHR) and ZonMw (the Netherlands Organisation for Health Research and Development) and Reumafonds (the Dutch Arthritis Foundation). Within 5 years, over 3000 patients will be enrolled, from all of whom biological samples will be analyzed in an attempt to transfer the current step-up treatment for JIA into personailsed or stratified therapy, with customised tretament plans for children in order to achieve clinical inactiev disease earlier, more often and with fewer side effects. Importantly, health economic analyses will ensure that the cost effectiveness of such a paradigm shift in treating our patients will be taken into account as well. Below, professor Nico Wulffraat, on behalf of the Dutch team in UCAN CAN DU, is receiving the cheque out of the hands of the Canadian Ambassodor in the Netherlands, mrs. Sabine Nolke.